Titlebook: COX-2 Blockade in Cancer Prevention and Therapy; Randall E. Harris Book 2003 Springer Science+Business Media New York 2003 Prevention of b

天气

凝乳

https://doi.org/10.1007/978-3-319-05410-0 a viable approach for the chemoprevention of colorectal cancer. This chapter will begin with a review of some of the key findings that led to the hypothesis that COX-2 inhibitor therapy inhibits colorectal cancer development followed by a discussion of the prostaglandin (PG) signaling pathways that have been linked to the carcinogenic process.

放弃

分开

2196-9906 onized cancer research. COX-2 Blockade in Cancer Prevention and Therapy chronicles the evidence and presents exciting new op­ portunities for the use of cyclooxygenase-2 (COX-2) blockade in the prevention and treatment of cancer. The text is divided broadly into five areas. First, an historical over

tolerance

配偶

Regulation of Expression and Potential Carcinogenic Role of Cyclooxygenase-2 . to the biologically active end products, PGD., PGE., PGF., PGI. (prostacyclin), and other related eicosanoids. These prostanoids contribute to many normal physiological processes including inflammation, pain and fever, and various cancers .

灿烂

整洁漂亮

食物

Suggestions

Cyclooxygenase-2, Prostaglandins, and Colorectal Carcinogenesis a viable approach for the chemoprevention of colorectal cancer. This chapter will begin with a review of some of the key findings that led to the hypothesis that COX-2 inhibitor therapy inhibits colorectal cancer development followed by a discussion of the prostaglandin (PG) signaling pathways that have been linked to the carcinogenic process.